Delivery Order SPE2DB25D3306-SPE2DB25FUCWD
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $18,978.90. This non-set-aside competitive award is scheduled for completion by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $14,404.90 to AmerisourceBergen Drug Corp for 60-tablet units of Eliquis 5 mg on July 22, 2025, with completion scheduled for July 23, 2025. This non-competitive, firm fixed-price delivery order was issued under a child contract arrangement and represents a pharmaceutical supply transaction for federal medical procurement. The award was performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) valued at $16,636.35 under a firm fixed-price contract. The award was made on August 25, 2025, with an ultimate completion date of August 26, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery of this pharmaceutical product from its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $15,087.05 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract. The award was made on August 4, 2025, with an ultimate completion date of August 5, 2025, with performance to be executed at the vendor's facility in Conshohocken, Pennsylvania. This non-set-aside delivery order represents a routine pharmaceutical procurement through the federal medical supply chain....
- The Defense Logistics Agency awarded a delivery order valued at $29,840.86 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract. The award was made on August 12, 2025, with an ultimate completion date of August 13, 2025, and performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $77,905.19 to AmerisourceBergen Drug Corp for 60-count bottles of Eliquis 5 mg tablets. This competitively awarded, firm fixed-price delivery order is set to be completed by August 25, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The contract represents a non-set-aside award, indicating that AmerisourceBergen competed against other vendors to secure this pharmaceutical supply contract....
- The Defense Logistics Agency awarded a delivery order valued at $10,427.06 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price contract. The award, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a non-competitive delivery against an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $12,237.66 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) on September 10, 2025, with completion scheduled for September 11, 2025. This non-competitive delivery order was issued under a firm fixed-price arrangement and performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical supply vendor,...
- The Defense Logistics Agency awarded a $12.5K delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This non-set-aside, firm fixed price delivery order is set to complete by August 13, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier within the federal healthcare procurement...
- The Defense Logistics Agency awarded a delivery order valued at $64,477.65 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) on September 9, 2025, with an ultimate completion date of September 10, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUCWDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $90,084.87 to AmerisourceBergen Drug Corp for 60-count bottles of Eliquis 5 mg tablets, with a completion date of September 4, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical supply services to support federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The parent IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including products for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Eliquis, an anticoagulant medication, represents one of many pharmaceutical products delivered through this strategic contract vehicle designed to meet federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $90.1k | 9/3/25 |